PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer-Reference-Cited by-同舟云学术

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

Published:2017-01 Issue:1 Volume:12 Page:110-120
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yu Hui^ORCID,Batenchuk Cory,Badzio Andrzej,Boyle Theresa A.,Czapiewski Piotr,Chan Daniel C.,Lu Xian,Gao Dexiang,Ellison Kim,Kowalewski Ashley A.,Rivard Christopher J.,Dziadziuszko Rafal,Zhou Caicun,Hussein Maen,Richards Donald,Wilks Sharon,Monte Marc,Edenfield William,Goldschmidt Jerome,Page Ray,Ulrich Brian,Waterhouse David,Close Sandra,Jassem Jacek,Kulig Kimary,Hirsch Fred R.

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Molecular genetics of small cell lung carcinoma;Wistuba;Semin Oncol,2001

2. Variable mutations of the RB gene in small-cell lung carcinoma;Mori;Oncogene,1990

3. Genetic changes in small cell lung carcinoma;Arriola;Clin Transl Oncol,2008

4. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches;Spigel;J Thorac Oncol,2013

5. A small-cell lung cancer genome with complex signatures of tobacco exposure;Pleasance;Nature,2010

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications;Journal of Molecular Medicine;2024-06-27

2. Serum albumin and derived neutrophil-to-lymphocyte ratio are potential predictive biomarkers for immune checkpoint inhibitors in small cell lung cancer;Frontiers in Immunology;2024-06-07

3. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27

4. Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?;Biomolecules;2024-03-25

5. Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer;Frontiers in Oncology;2024-01-09